# Dose-effect Relationship of Rt-PA on ICH Evacuation

Study · id `cardio:ct-nct02472574` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02472574](<https://clinicaltrials.gov/study/NCT02472574>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02472574

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 108 participants.

## Technical summary

Registry record NCT02472574. Randomized; no masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2018-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 108 participants (planned count; ClinicalTrials.gov record NCT02472574, source copy `cardio:ctgov-nct02472574-2015-06-16`, retrieved 2026-10-31)
- Start date: 2015-06 (registry gives no type) (ClinicalTrials.gov record NCT02472574, source copy `cardio:ctgov-nct02472574-2015-06-16`, retrieved 2026-10-31)
- Primary completion: 2018-06 (anticipated) (ClinicalTrials.gov record NCT02472574, source copy `cardio:ctgov-nct02472574-2015-06-16`, retrieved 2026-10-31)
- Completion: 2018-06 (anticipated) (ClinicalTrials.gov record NCT02472574, source copy `cardio:ctgov-nct02472574-2015-06-16`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02472574, source copy `cardio:ctgov-nct02472574-2015-06-16`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02472574-2015-06-16`, retrieved 2026-10-31)

## The registry's words

- Brief title: Dose-effect Relationship of Rt-PA on ICH Evacuation
- Condition: Hypertensive Intracerebral Hemorrhage
- Intervention (Device): YL-1 type of intracranial hematoma puncture needle
- Intervention (Drug): rt-PA
- Lead sponsor: Tongji Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry lists this organization as the lead sponsor: Tongji Hospital (`cardio:org-tongji-hospital`)

## Provenance

Content hash: 6483d34b2614eb2bd74fba553060b3737d5f7283ab7fa05d2fbb93e52aaeb723
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
